Earnings · China A-shares
Shandong Buchang Pharmaceuticals Co., Ltd. Class A (603858) earnings
Shandong Buchang Pharmaceuticals Co., Ltd. Class A published its Q3 report on 2026-10-29: net profit -9.09% year on year, -5.66% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved +5.96% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-29
- Period end
- 2026-09-30
- Net profit YoY
- -9.09%
- Excl. one-offs YoY
- -5.66%
- Net profit QoQ
- +57.42%
- Result
- Neutral
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +3.84% | — |
| 3 days | +5.96% | — |
| 7 days | +5.88% | — |
| 14 days | +3.76% | — |
Report history
Over the last 8 reports, net profit grew year on year in 5 of them. The stock rose in the 3 trading days after 4 of 6 reports (average +1.39%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-30 | ¥789.37M | -9.09% | -5.66% | -5.33% | 0.75 | 7.74% | +5.96% | — | — |
| 2026 interim report | 2026-08-28 | ¥502.59M | -19.93% | -17.74% | -11.67% | 0.48 | 4.93% | -2.97% | -6.38% | +3.31% |
| 2026 Q1 report | 2026-04-28 | ¥320.41M | +4.28% | +3.54% | -7.39% | 0.30 | 3.16% | +0.49% | -10.62% | -10.00% |
| 2025 annual report | 2026-04-28 | ¥360.78M | +165.15% | +228.83% | +7.90% | 0.34 | 3.58% | +0.49% | -10.62% | -10.00% |
| 2025 Q3 report | 2025-10-30 | ¥868.32M | +177.54% | +138.26% | -0.54% | 0.82 | 8.23% | -4.86% | -8.62% | -3.87% |
| 2025 interim report | 2025-08-28 | ¥627.70M | +171.24% | +180.04% | +4.27% | 0.59 | 5.99% | +4.96% | -2.98% | -8.48% |
| 2025 Q1 report | 2025-04-26 | ¥307.26M | +169.49% | +197.05% | +5.47% | 0.29 | 2.97% | +4.78% | +11.82% | +8.57% |
| 2024 annual report | 2025-04-26 | -¥553.80M | -273.62% | — | -16.91% | -0.51 | -5.07% | +4.78% | +11.82% | +8.57% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.